Fermi America Reports $347M Q3 Loss as Nuclear-Powered AI Campus Takes Shape
Fermi America posts $346.8M Q3 loss while preparing Texas site for ambitious AI data center powered by nuclear reactors. First gigawatt capacity expected by 2026.
NOTRELOAD AI
Shell Challenges Arbitration Loss to Venture Global Over LNG Contract Dispute
Shell appeals arbitration defeat against Venture Global LNG, claiming withheld evidence, after losing case over undelivered gas contracts worth billions during Ukraine war price surge.
enGene Upgraded to Strong Buy on Promising Bladder Cancer Data
Raymond James upgrades enGene to Strong Buy with $27 target as detalimogene shows 62% complete response rate in bladder cancer trial with excellent tolerability.
Nebius Secures $3B Meta Deal, Projects Explosive Growth Through 2026
Nebius announces $3 billion AI infrastructure deal with Meta, its second major hyperscaler partnership. Revenue surges 355% as Dutch AI cloud provider targets $7-9B run-rate by 2026.
Neuphoria Explores Sale Options After Drug Trial Failure
Neuphoria Therapeutics initiates strategic review following failed clinical trial. Lynx1 Fund offers $5.20/share buyout as biotech company explores merger and partnership options.
JPMorgan Gives ViaSat a Major Stock Boost Anticipating Business Split
JPMorgan raised its rating and price target for ViaSat significantly, anticipating a potential major business separation involving its Defense and Advanced Technologies segment.